Patel Sanj K sold KNSA
April 29, 2026 · Form 4 insider transaction
Patel Sanj K sold 22,544 shares of Kiniksa Pharmaceuticals International, plc at $54.01 per share, a transaction worth $1.22M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
22,544
Price
$54.01
Total value
$1.22M
InsiderPatel Sanj K
RoleOfficer, Director
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateApril 29, 2026
Filing dateApril 30, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025.; This transaction was executed in multiple trades through a broker-dealer at prices ranging between $54.00 and $54.225. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.